ZURICH (Reuters) - Patients suffering from the most severe form of childhood arthritis were less likely to experience a flare up in the disease when using Novartis' drug Ilaris compared to a placebo, the Swiss drugmaker said on Wednesday.
Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/5_7nLvMWrX4/us-novartis-arthritis-ilaris-idUSBRE85506820120606
phlebotomy courses in bay area phlebotomy training in maryland phlebotomy training california
No comments:
Post a Comment